T2-Low Asthma: A Discussed but Still Orphan Disease
Sign Up to like & getrecommendations! Published in 2023 at "Biomedicines"
DOI: 10.3390/biomedicines11041226
Abstract: Asthma affects 10% of the worldwide population; about 5% of cases are severe with the need for target therapies such as biologics. All the biologics approved for asthma hit the T2 pathway of inflammation. T2-high… read more here.
Keywords: asthma; discussed still; low asthma; orphan disease ... See more keywords